PIN1 and breast cancer: Moreover, inhibiting Pin1 sensitizes many cancer cells to chemotherapy, including HCC to sorafenib228, breast cancer to trastuzumab229, rapamycin53, Taxol and 5-fluorouracil141, colon cancer to Taxol84, and AML to retinoic acid81.